193 related articles for article (PubMed ID: 3452240)
21. Selective parenteral and enteral antisepsis regimen (SPEAR).
Gould IM
Br J Hosp Med; 1990 Sep; 44(3):209-11. PubMed ID: 2257406
[TBL] [Abstract][Full Text] [Related]
22. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
[TBL] [Abstract][Full Text] [Related]
23. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
[TBL] [Abstract][Full Text] [Related]
24. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.
Kelsey SM; Goldman JM; McCann S; Newland AC; Scarffe JH; Oppenheim BA; Mufti GJ
Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of disseminated Fusarium infection in an infant with leukemia.
Okada H; Hamatani S; Kondo M; Imai T; Itoh S; Isobe K; Onishi S
Int J Hematol; 2000 Dec; 72(4):494-8. PubMed ID: 11197219
[TBL] [Abstract][Full Text] [Related]
26. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
27. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
Isaacs D
Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968
[TBL] [Abstract][Full Text] [Related]
28. [Antimicrobial prophylaxis and therapy in neutropenia].
Link H
Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
[TBL] [Abstract][Full Text] [Related]
29. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
[TBL] [Abstract][Full Text] [Related]
30. Problems and results of selective decontamination in leukemia patients.
Günther I; Brijmohan-Günther R; Kundt G; Kaben U; Teseler RM
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):197-204. PubMed ID: 3914742
[TBL] [Abstract][Full Text] [Related]
31. [Etiological analysis of 67 cases of acute leukemia combined with fungal infection].
Liang L; Su LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):218-21. PubMed ID: 19236783
[TBL] [Abstract][Full Text] [Related]
32. Fungal respiratory disease.
Yao Z; Liao W
Curr Opin Pulm Med; 2006 May; 12(3):222-7. PubMed ID: 16582678
[TBL] [Abstract][Full Text] [Related]
33. Exogenous fungal endophthalmitis: microbiology and clinical outcomes.
Wykoff CC; Flynn HW; Miller D; Scott IU; Alfonso EC
Ophthalmology; 2008 Sep; 115(9):1501-7, 1507.e1-2. PubMed ID: 18486220
[TBL] [Abstract][Full Text] [Related]
34. [Prophylaxis against mycoses in neutropenic patients].
Arning M; Aul C
Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
[TBL] [Abstract][Full Text] [Related]
35. [Infections of the central nervous system in malignant hemopathies].
Escudier E; Cordonnier C; Poirier J
Rev Neurol (Paris); 1986; 142(2):116-25. PubMed ID: 3726388
[TBL] [Abstract][Full Text] [Related]
36. [The effect of oral high-dose amphotericin B in patients with acute leukemia: detection of fungi and prophylaxis for fungal infection].
Motomura S; Noguchi T; Kanamori H; Murata T; Harano H; Takahashi K; Matsuzaki M; Miyashita H; Ogawa K; Ito A
Rinsho Ketsueki; 1987 Nov; 28(11):1956-62. PubMed ID: 3446867
[No Abstract] [Full Text] [Related]
37. [Invasive fungal infections in hematologic malignancies--a retrospective study of 61 autopsied cases].
Kuzuyama Y; Fujii H; Kitagawa Y; Yashige H; Horishi H; Suyama Y; Miyoshi M
Gan No Rinsho; 1990 Jul; 36(8):899-902. PubMed ID: 2366325
[TBL] [Abstract][Full Text] [Related]
38. [Clinical approach to infection in patients with hematologic malignancy].
Funada H
Gan To Kagaku Ryoho; 1992 Feb; 19(2):178-83. PubMed ID: 1371045
[TBL] [Abstract][Full Text] [Related]
39. [Clinical course and risk factors in patients with generalized mycoses].
von Eiff M; Essink M; Fegeler W; Schellong S; Schmidt H; Hiddemann W; Büchner T; van de Loo J
Schweiz Med Wochenschr; 1988 Apr; 118(16):584-91. PubMed ID: 3381072
[TBL] [Abstract][Full Text] [Related]
40. [Recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the prevention of invasive fungal infection due to filamentous fungi].
Ruiz-Camps I; Aguado JM; Almirante B; Bouza E; Ferrer Barbera C; Len O; López-Cerero L; Rodríguez-Tudela JL; Ruiz M; Solé A; Vallejo C; Vázquez L; Zaragoza R; Cuenca-Estrella M;
Enferm Infecc Microbiol Clin; 2010 Mar; 28(3):172.e1-172.e21. PubMed ID: 20202721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
